PATENT CLAIM ANALYSIS

Application Number: 16287771
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["549", "408000"]

Abstract:
The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.

Claim (Index 13):
The compound of  claim 12 , wherein the compound formula is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 99.0
- Lexical Diversity: 1.13636
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11046664', '13873591', '13560131', '12670989', '13308612']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588742460896849
- 35 USC 102 Novelty (BERT): 0.5069434903152822
- Combined Prediction Score: 0.7336811705122447
- Mean Citation Score: 260.24751000000003
- Max Citation Score: 261.19708
- Similarity Product: 172.2173464861775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test